AVC-U2
Undenatured Collagen Type II
AVC-U2 takes the form of a bright white fiber structure of low density. The color is indicative of the lack of impurities.
Avicenna’s undenatured chicken collagen Type II raw material, AVC-U2, is described as ~98% undenatured Type II collagen protein, with proprietary US patent protection and applications pending in Canada and the EU.
~98% undenatured Type II collagen protein (as stated on Avicenna’s public product materials).
- US Patent 11702447B2
- Patent pending in Canada and the European Union (EPO Rule 71(3) communication issued, indicating intent to grant)
Testing specifications
- Sterilization
- Extraction of the collagen
- Separation of the collagen
- Concentration of the purified collagen
Key highlights
- ·Described as a bright white fiber structure of low density—the color narrative is tied to cleanliness / lack of impurities on Avicenna’s page
- ·Low-temperature extraction to avoid breaking the natural structure; positioned to preserve the triple helix
- ·Developed from lab-scale purification understanding through scale-up aimed at competitive quality and pricing
- ·Public positioning emphasizes strategic partnership or acquisition (not necessarily bulk commodity spot supply)
Overview
Avicenna frames AVC-U2 as undenatured chicken collagen Type II with joint-health positioning and references to pathways associated with autoimmune-related joint concerns (for example, rheumatoid arthritis) in public marketing language.
The extraction narrative singles out Type II protein from chicken cartilage and emphasizes maintaining native structural features versus hydrolyzed peptide approaches.
Process narrative (public reference)
Avicenna describes starting from lab-scale purification concepts, improving techniques for manufacturing applicability, then iterating on yield and scale-up to supply undenatured collagen at competitive parameters—subject to independent verification for any commercial program you pursue.
Typical applications
- Premium human joint-health / wellness concepts where undenatured Type II is the differentiator
- Programs requiring patent-backed storytelling and diligence on exclusivity / licensing
- Clinical or Rx-adjacent concepts only where your regulatory path supports the ingredient class
Product summaries, specifications language, and imagery below are aligned to Avicenna Nutraceutical’s public products page for reference only. L&M is not Avicenna; confirm specifications, regulatory status, patents, and supply terms with your manufacturer or licensor before formulation or claims.